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CASE REPORT
A unique effect of clonazepam on frontal lobe seizure
control
TAHIR OBEID, ADNAN AWADA, NAJLA SAYES, YAHYA MOUSALI & CATHERINE HARRIS
Neurology Sections, King Khalid and King Fahad National Guard Hospitals, Jeddah, Kingdom of Saudi
Arabia
Correspondence to: Dr Tahir Obeid, MRCP (UK), Consultant Neurologist & Section Head, King Khalid National
Guard Hospital, P.O. Box 9515, Jeddah 21423, Kingdom of Saudi Arabia
In a 16-year-old female, clonazepam (CZP) changed randomly occurring intractable tonic seizures of frontal lobe origin to a
few sleep seizures when used as an adjunctive therapy. The significance of this change in the seizure pattern is discussed with
an explanation of possible pathophysiologic mechanism.
c© 1999 BEA Trading Ltd
Key words: clonazepam; sleep; tonic seizures; frontal lobe epilepsy.INTRODUCTION
Clonazepam (CZP) (a 1.4 benzodiazapine) is effec-
tive in myoclonic and generalized absence seizures,
but less so in generalized tonic–clonic seizures1, 2. It
may exacerbate generalized tonic–clonic seizures and
may be disadvantageous in patients with juvenile my-
oclonic epilepsy3, 4. Hence, CZP is rarely used as a
primary antiepileptic drug, though it still has a role as
an adjunctive therapy.
We describe a case of intractable frontal lobe tonic
seizures in which CZP was successful in changing the
randomly occurring rhythm of the tonic seizures to a
sleep pattern, though CZP was previously reported to
exacerbate tonic seizures5. Our purpose of reporting
this case is to document such a unique finding and sec-
ondly to discuss its significance.
CASE REPORT
A 16-year-old Saudi girl was referred to King Khalid
National Guard Hospital (KKNGH) Epilepsy Clinic
on May 1994 for evaluation of intractable epilepsy.
The patient was a product of normal pregnancy and
delivery. Her parents were unrelated and had no fam-1059–1311/99/070431 + 03 $12.00/0ily history of epilepsy. As a baby, she was well until
the age of 6 months when she was hospitalized with
a febrile illness that lasted for 2 weeks. She then de-
veloped brief attacks of tonic seizures which occurred
randomly. She was prescribed an unspecified anticon-
vulsant medication, which resulted in complete con-
trol of the fits. After 6 months of treatment, the mother
discontinued the medication and 4 months later the
child started to have 3–4 seizures when asleep and
similar numbers while awake. At age 4, the seizure fre-
quency increased to 10 during both awake and sleep
periods. She was given phenytoin 100 mg daily and
carbamazepine was added subsequently at a dose of
200 mg TID to no avail. At age 11, valproic acid was
added at a dose of 200 mg TID and did not influ-
ence the seizure frequency. When seen in KKNGH
Epilepsy Clinic, she was on carbamazepine 400 mg
TID and vigabatrin 500 mg TID but continued to have
frequent seizures. She was admitted for documenta-
tion of the seizures regarding their nature and fre-
quency during awake and sleep periods; and also to
observe her sleep quality and quantity. During the hos-
pital stay the seizures were witnessed as follows: the
patient developed tonic deviation of neck and tonic
extension of her limbs with upper limbs more af-
fected than the lower with complete loss of conscious-c© 1999 BEA Trading Ltd
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followed by post-ictal confusion lasting 4–5 minutes
and at times were associated with a brief automatism.
When asleep, the seizures woke her up and it took her
10–15 minutes to resume sleep again. She had 20–
40 seizures while asleep and 5–10 during the awake
state. In the absence of video-EEG polysmnography,
several EEGs were performed which documented that
most seizures were detected during drowsiness. The
EEGs showed frequent discharges of spike, sharp and
sometimes slow wave complexes seen predominantly
in the right frontal regions, occasionally bilateral and
rarely generalized. Two previous MRI scans were nor-
mal and a third MRI scan while in hospital showed a
discrete lesion of high intensity signal on T2-weighted
images of the right anterior aspect of the opercula ad-
jacent to the Sylvian region. This discrete lesion dis-
appeared on a subsequent MRI and hence we specu-
lated that it was a transient, seizure-related abnormal-
ity. The patient was diagnosed as having supplemen-
tary motor seizures. During hospitalization, acetazo-
lamide and pyridoxine were tried in desperation with
no effect. Lamotrigine was introduced at a dose of
50 mg BID and increased to 100 mg BID to no avail.
Clonazepam was then introduced at a dose of 0.5 mg
BID and on reaching a dose of 1 mg BID, complete
control of the seizures during the awake period and re-
duction of sleep seizures to 3–4 a day was achieved.
The patient was discharged home on clonazepam, vi-
gabatrin, valproic acid and carbamazepine. She was
referred to an Epilepsy Center for further management
where vigabatrin and clonazepam were discontinued
and primidone was introduced at a dose of 250 mg
BID. The patient reported back to us because of the
recurrence and worsening of both awake and sleep
seizures, as a result of which she fell down and sus-
tained trauma to the skull. She was admitted to the
intensive care unit (ICU) for seizure monitoring and
clonazepam was re-introduced at a dose of 1 mg BID
with complete control of the awake seizures and a sig-
nificant reduction of the sleep seizures to 3–4 a day
which was similar to the CZP effect when it was ini-
tially introduced. The carbamazepine and the primi-
done were discontinued and she was discharged to be
followed in the clinic. In the past 3 months, the patient,
on clonazepam and valaproic acid, has had no seizures
during the awake period with only 3–4 seizures during
sleep according to the seizure calendar recorded by the
parents. She was able for the first time as a teenager to
leave her house and socialize with friends.DISCUSSION
Frontal lobe seizures may occur primarily or predom-
inantly during sleep6–8. The inter-ictal epileptiform
discharges are more prevalent during non-rapid eye
movement (NREM) sleep than during rapid eye move-
ment (REM) sleep6–8. In our patient, the frontal lobe
seizures occurred randomly during the wake–sleep cy-
cle and were resistant to different types of anticonvul-
sants used singly or in combination. It is only through
the addition of CZP that the awake seizures were com-
pletely stopped and the sleep ones were reduced sig-
nificantly. This improvement may possibly be a result
of improving the sleep pattern of the patient. Prior to
CZP introduction, the patient’s sleep was fragmented
by repeated arousal and there was reduction of sleep
efficacy as documented by ICU nurses on the two oc-
casion during hospitalization. The sleep deprivation
effect of the seizures may have a role in provoking the
seizure occurrence during awake and sleep states.
We cannot dismiss the possibility that the long du-
ration of action of clonazepam might have a direct ef-
fect on reduction of both sleep and awake discharges
as clonazepam’s half-life is 20–80 hours9. This may
be difficult to reconcile with the fact that benzodi-
azepines are known to reduce NREM sleep onset la-
tency, elevate the time spent in light REM during
which time epileptogenic discharges are proved to be
increased8, 10. The response of our patient and the ex-
cellent control of the rolandic discharges in children
with rolandic epilepsy of centrotemporal spike sup-
ports the notion that clonazepam can affect sleep and
seizures jointly or independently10, 11. The major dis-
advantage of clonazepam is tolerance in long-term
usage. This problem can be helped by using clon-
azepam on an alternate day regimen as clonazepam
is slowly eliminated9. Recently, flumazenil may pos-
sibly reverse tolerance without provoking withdrawal
seizures as shown in a preliminary report, but the prob-
lems of tolerance have not yet been fully resolved12.
In conclusion, we think that there is still a role for
clonazepam as an adjunctive therapy particularly in
sleep seizures and we recommend its trial in resistant
cases of sleep epilepsy syndromes.
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